[Company Performance]: Financial results like revenue, earnings, and profitability directly impact investor confidence and stock price.

[Clinical Trial Results]: Success or failure in clinical trials for CRMD's drug candidates significantly influences stock valuation due to potential future revenue.

[Regulatory Approvals]: FDA or other regulatory body approvals for CRMD's drugs drive investor excitement and increase the stock price.

[Market Sentiment]: Overall market conditions and investor mood towards the pharmaceutical or biotechnology sector can affect CRMD's stock price.

[Competition]: The presence of competing drugs or treatments can impact CRMD's market share and, consequently, its stock price.

[Partnerships & Collaborations]: Forming strategic alliances or collaborations with other companies can increase investor confidence and boost the stock price.

[Management Team]: Changes in management or perception of leadership competence can influence investor sentiment and stock performance.

[Economic Factors]: Economic indicators such as interest rates, inflation, and economic growth can indirectly affect the stock market and CRMD's stock.

[Debt & Cash Flow]: Company's financial health, including its debt levels and cash flow, plays a vital role in determining its stock price.

[Analyst Ratings]: Stock analysts' ratings and price targets can influence investor decisions and cause fluctuations in CRMD's stock price.